Boone Capital Management
Latest statistics and disclosures from Boone Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MDT, MIRM, IONS, CI, BMRN, and represent 49.76% of Boone Capital Management's stock portfolio.
- Added to shares of these 8 stocks: AstraZeneca (+$20M), HQY (+$20M), TYRA (+$11M), LIVN (+$7.4M), WVE (+$6.0M), BMRN, CI, UNH.
- Started 4 new stock positions in TYRA, HQY, AstraZeneca, WVE.
- Reduced shares in these 10 stocks: BBIO (-$21M), , COGT (-$14M), RAPT (-$11M), MIRM (-$9.0M), QURE (-$8.6M), CLPT (-$6.2M), KOD (-$5.9M), ABEO, NBIX.
- Sold out of its positions in ABEO, CLPT, COGT, ICLR, QURE.
- Boone Capital Management was a net seller of stock by $-23M.
- Boone Capital Management has $319M in assets under management (AUM), dropping by 4.47%.
- Central Index Key (CIK): 0001882053
Tip: Access up to 7 years of quarterly data
Positions held by Boone Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Boone Capital Management
Boone Capital Management holds 15 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Medtronic SHS (MDT) | 12.9 | $41M | 429k | 96.06 |
|
|
| Mirum Pharmaceuticals (MIRM) | 10.4 | $33M | -21% | 421k | 78.99 |
|
| Ionis Pharmaceuticals (IONS) | 10.4 | $33M | 418k | 79.11 |
|
|
| Cigna Corp (CI) | 8.3 | $27M | +16% | 97k | 275.23 |
|
| BioMarin Pharmaceutical (BMRN) | 7.7 | $25M | +25% | 412k | 59.43 |
|
| Neurocrine Biosciences (NBIX) | 6.8 | $22M | -8% | 152k | 141.83 |
|
| UnitedHealth (UNH) | 6.4 | $20M | +6% | 62k | 330.11 |
|
| Astrazeneca Sponsored Adr | 6.4 | $20M | NEW | 220k | 91.93 |
|
| Healthequity (HQY) | 6.1 | $20M | NEW | 213k | 91.61 |
|
| Livanova SHS (LIVN) | 5.6 | $18M | +72% | 289k | 61.53 |
|
| Rapt Therapeutics Com New (RAPT) | 5.0 | $16M | -39% | 471k | 33.87 |
|
| Bridgebio Pharma (BBIO) | 4.4 | $14M | -59% | 185k | 76.49 |
|
| Kodiak Sciences (KOD) | 4.4 | $14M | -29% | 504k | 27.96 |
|
| Tyra Biosciences (TYRA) | 3.3 | $11M | NEW | 399k | 26.29 |
|
| Wave Life Sciences SHS (WVE) | 1.9 | $6.0M | NEW | 352k | 17.00 |
|
Past Filings by Boone Capital Management
SEC 13F filings are viewable for Boone Capital Management going back to 2022
- Boone Capital Management 2025 Q4 filed Feb. 17, 2026
- Boone Capital Management 2025 Q3 filed Nov. 14, 2025
- Boone Capital Management 2025 Q2 filed Aug. 14, 2025
- Boone Capital Management 2025 Q1 filed May 15, 2025
- Boone Capital Management 2024 Q4 filed Feb. 14, 2025
- Boone Capital Management 2024 Q3 filed Nov. 14, 2024
- Boone Capital Management 2024 Q2 filed Aug. 14, 2024
- Boone Capital Management 2024 Q1 filed May 15, 2024
- Boone Capital Management 2023 Q4 filed Feb. 14, 2024
- Boone Capital Management 2023 Q3 filed Nov. 14, 2023
- Boone Capital Management 2023 Q2 filed Aug. 14, 2023
- Boone Capital Management 2023 Q1 filed May 15, 2023
- Boone Capital Management 2022 Q4 filed Feb. 14, 2023